IBB
iShares Biotechnology ETF
Price Chart
Latest Quote
$212.20
+3.51 (+1.68%)
Current Price
| Previous Close | $208.69 |
| Open | $207.91 |
| Day High | $212.20 |
| Day Low | $206.02 |
| Volume | 1,634,898 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.16% |
| Net Assets | $11.20B |
| Expense Ratio | 0.44% |
| Category | Health |
| Fund Family | iShares |
| Net Asset Value | $208.68 |
| Premium/Discount | 1.69% |
| Quarterly Dividend Yield | 0.16% |
| P/E Ratio | 26.51 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $206.22 |
| SMA50 | $208.01 |
| SMA200 | $184.02 |
| RSI | 59.63 |
| ATR | 5.0129 |
| Rel Volume | 0.98 |
Performance History
| Week | +0.81% |
| Month | +0.71% |
| Quarter | +12.56% |
| 6 Months | +26.48% |
| YTD | +25.68% |
| Year | +37.04% |
| 3 Years | +82.41% |
| 5 Years | +36.52% |
| 10 Years | +150.69% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $212.20 | 1,639,100 |
| 2026-10-26 | $208.69 | 765,500 |
| 2026-10-23 | $207.74 | 830,300 |
| 2026-10-22 | $209.54 | 2,165,900 |
| 2026-10-21 | $211.55 | 1,365,400 |
| 2026-10-20 | $210.50 | 1,753,600 |
| 2026-10-19 | $204.06 | 945,300 |
| 2026-10-16 | $201.99 | 1,762,600 |
| 2026-10-15 | $207.41 | 1,836,400 |
| 2026-10-14 | $203.25 | 1,129,000 |
| 2026-10-13 | $200.02 | 1,107,700 |
| 2026-10-12 | $204.26 | 1,157,200 |
| 2026-10-09 | $206.49 | 2,455,100 |
| 2026-10-08 | $200.48 | 3,615,000 |
| 2026-10-07 | $203.34 | 1,477,400 |
| 2026-10-06 | $203.10 | 2,442,600 |
| 2026-10-05 | $207.96 | 1,549,400 |
| 2026-10-02 | $205.29 | 2,090,300 |
| 2026-10-01 | $205.96 | 1,546,800 |
| 2026-09-30 | $210.53 | 1,939,200 |
| 2026-09-29 | $211.04 | 1,621,300 |
| 2026-09-28 | $210.71 | 811,300 |
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on IBB.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.